Antiarrhythmic drugs (AADs ... To date, there is no sufficient evidence to support the use of any upstream therapy after AF catheter ablation. Larger registries and controlled clinical trials ...

The first-line therapy for arrhythmogenic right ventricular ... However, the efficacy of antiarrhythmic agents has not been rigorously evaluated in patients with ARVC, and limited data are ...

The Vaughan-Williams classification is the system used to categorize antiarrhythmic drug therapy into class IA, class IB, class IC, class II, class III, class IV and class V. See antiarrhythmic ...

His group's prior VANISH trial showed that when antiarrhythmic drugs are not working, it's better to go to ablation than ...

whether alone or in combination with another antiarrhythmic therapy. Some issues related to the pathophysiology of human AF, which could inform future therapeutic decisions, remain to be studied ...

In 19 of these the arrhythmias were terminated without specific antiarrhythmic therapy after treatment with antibiotics, bronchodilator drugs and intermittent positive-pressure breathing.

The use of AADs in the early period after AF aims to reduce early recurrence of atrial arrhythmia or the occurrence of macroreentrant LA tachycardia, during the 'blanking period'. Early recurrence ...